233 related articles for article (PubMed ID: 24780384)
1. Dienogest was effective in treating hemorrhagic ascites caused by endometriosis: a case report.
Asano R; Nakazawa T; Hirahara F; Sakakibara H
J Minim Invasive Gynecol; 2014; 21(6):1110-2. PubMed ID: 24780384
[TBL] [Abstract][Full Text] [Related]
2. [Endometriosis with massive hemorrhagic ascites: a case report and review of the literature].
Ekoukou D; Guilherme R; Desligneres S; Rotten D
J Gynecol Obstet Biol Reprod (Paris); 2005 Jun; 34(4):351-9. PubMed ID: 16136662
[TBL] [Abstract][Full Text] [Related]
3. Hemorrhagic ascites associated with endometriosis. A case report.
Dias CC; Andrade JM; Ferriani RA; Villanova MG; Meirelles RS
J Reprod Med; 2000 Aug; 45(8):688-90. PubMed ID: 10986691
[TBL] [Abstract][Full Text] [Related]
4. Dienogest: a new therapeutic agent for the treatment of endometriosis.
Harada T; Taniguchi F
Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868
[TBL] [Abstract][Full Text] [Related]
5. Recurrent massive ascites due to mossy endometriosis.
Dun EC; Wong S; Lakhi NA; Nehzat CH
Fertil Steril; 2016 Nov; 106(6):e14. PubMed ID: 27542707
[TBL] [Abstract][Full Text] [Related]
6. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis.
Tamura H; Yoshida H; Kikuchi H; Josaki M; Mihara Y; Shirafuta Y; Shinagawa M; Tamura I; Taketani T; Takasaki A; Sugino N
J Ovarian Res; 2019 Dec; 12(1):123. PubMed ID: 31831028
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
[TBL] [Abstract][Full Text] [Related]
8. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
[TBL] [Abstract][Full Text] [Related]
9. Novel triple therapy for hemorrhagic ascites caused by endometriosis: A case report.
Han X; Zhang ST
World J Clin Cases; 2020 Dec; 8(23):6206-6212. PubMed ID: 33344624
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data.
Lee JH; Song JY; Yi KW; Lee SR; Lee DY; Shin JH; Cho S; Seo SK; Kim SH
Reprod Sci; 2018 Oct; 25(10):1515-1522. PubMed ID: 29848190
[TBL] [Abstract][Full Text] [Related]
11. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
12. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
Seo JW; Lee DY; Kim SE; Yoon BK; Choi D
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
Lee DY; Lee JY; Seo JW; Yoon BK; Choi D
Arch Gynecol Obstet; 2016 Nov; 294(6):1257-1263. PubMed ID: 27549091
[TBL] [Abstract][Full Text] [Related]
14. Massive recurrent hemoperitoneum with encapsulating peritonitis: another enigmatic clinical feature of endometriosis.
Gonzalez A; Artazcoz S; Elorriaga F; Palin H; Carugno J
Fertil Steril; 2019 Dec; 112(6):1190-1192. PubMed ID: 31843096
[TBL] [Abstract][Full Text] [Related]
15. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.
Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
Int J Gynaecol Obstet; 2012 Jun; 117(3):228-33. PubMed ID: 22459918
[TBL] [Abstract][Full Text] [Related]
16. Endometriosis presenting with recurrent massive hemorrhagic ascites and diagnosed by core needle biopsy: A case report.
Wang X; Li Y; Tong J; Chang B; Zhang Y; Liu Y; Bing H; Guo L; Li D
Medicine (Baltimore); 2019 May; 98(19):e15477. PubMed ID: 31083181
[TBL] [Abstract][Full Text] [Related]
17. Recurrent hemorrhagic ascites: a rare presentation of endometriosis.
Palayekar M; Jenci J; Carlson JA
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):521-2. PubMed ID: 17666650
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis-associated massive ascites in a young Nigerian lady.
Adeniran AS; Ijaiya MA; Ibrahim KOO; Ibrahim S; Folaranmi OO
Ghana Med J; 2023 Jun; 57(2):161-164. PubMed ID: 38504753
[TBL] [Abstract][Full Text] [Related]
19. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries.
Koshiba A; Mori T; Okimura H; Akiyama K; Kataoka H; Takaoka O; Ito F; Matsushima H; Kusuki I; Kitawaki J
J Obstet Gynaecol Res; 2018 Oct; 44(10):1970-1976. PubMed ID: 29992672
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study.
Maiorana A; Alfano P; Mercurio A; Marcantonio S; Minneci G; Incandela D; Audino P
Arch Gynecol Obstet; 2023 May; 307(5):1503-1512. PubMed ID: 36738318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
